BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 10598177)

  • 1. [Re: Prostaglandin E1 for prevention of contrast medium-induced kidney dysfunction. Fortsch Röntgenstr 170 (1999) 557-563].
    Fröhlich J
    Rofo; 1999 Oct; 171(4):342-3. PubMed ID: 10598177
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prostaglandin E1 for prevention of contrast medium-induced kidney dysfunction].
    Koch JA; Sketch M; Brinker J; Bernink PJ
    Rofo; 1999 Jun; 170(6):557-63. PubMed ID: 10420905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prevention of acute renal failure in suprarenal aortic surgery. Results of a pilot study].
    Torsello G; Kutkuhn B; Kniemeyer H; Sandmann W
    Zentralbl Chir; 1993; 118(7):390-4. PubMed ID: 8372519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Contrast medium induced nephropathy: pathogenesis, clinical aspects, prevention].
    Haller C; Kübler W
    Dtsch Med Wochenschr; 1999 Mar; 124(11):332-6. PubMed ID: 10209535
    [No Abstract]   [Full Text] [Related]  

  • 5. Multimodality prevention of contrast-induced acute kidney injury.
    McCullough PA
    Am J Kidney Dis; 2008 Feb; 51(2):169-72. PubMed ID: 18215694
    [No Abstract]   [Full Text] [Related]  

  • 6. [Recommendations for prevention of roentgen contrast medium-induced nephropathy].
    Möckel M; Bahr F; Leuner Ch; Kuhn H; Dietz R
    Z Kardiol; 2002 Sep; 91(9):719-26. PubMed ID: 12448072
    [No Abstract]   [Full Text] [Related]  

  • 7. [Contrast-induced nephropathy after computer tomography. Hydration and adapted contrast media dosage for the best prophylaxis].
    Haglund M; Hesselstrand R; Nyman U; Sterner G
    Lakartidningen; 2005 Oct 3-9; 102(40):2864-6, 2869-70. PubMed ID: 16255363
    [No Abstract]   [Full Text] [Related]  

  • 8. Contrast media-associated nephrotoxicity.
    Rudnick MR; Berns JS; Cohen RM; Goldfarb S
    Semin Nephrol; 1997 Jan; 17(1):15-26. PubMed ID: 9000546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haemodialysis for the prevention of contrast-induced nephropathy: outcome of 31 patients with severely impaired renal function, comparison with patients at similar risk and review.
    Huber W; Jeschke B; Kreymann B; Hennig M; Page M; Salmhofer H; Eckel F; Schmidt U; Umgelter A; Schweigart U; Classen M
    Invest Radiol; 2002 Sep; 37(9):471-81. PubMed ID: 12218442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pathophysiology and prevention of contrast-induced acute renal failure].
    Graziani G; Degnoni V; Oldani S; Buskermolen M; Brambilla G
    G Ital Nefrol; 2007; 24 Suppl 38():20-4. PubMed ID: 17922443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of atorvastatin (80 mg) in prevention of contrast-induced nephropathy in patients with chronic renal disease.
    Toso A; Maioli M; Leoncini M; Gallopin M; Tedeschi D; Micheletti C; Manzone C; Amato M; Bellandi F
    Am J Cardiol; 2010 Feb; 105(3):288-92. PubMed ID: 20102936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Acute renal insufficiency caused by contrast media. Prospective study on incidence, predisposing factors and course of the disease].
    Gamba G; Arizpe D; Ferral H; Contreras AM; Cortés J; Mendoza A; Malé R; Viniegra L; Peña JC
    Rev Invest Clin; 1988; 40(4):385-9. PubMed ID: 3244915
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevention of contrast induced nephropathy--an update.
    Gupta S; Gupta BM
    Indian Heart J; 2007; 59(4):375-7. PubMed ID: 19126948
    [No Abstract]   [Full Text] [Related]  

  • 14. Acetylcysteine in the prevention of contrast-induced nephropathy: a case study of the pitfalls in the evolution of evidence.
    Bagshaw SM; McAlister FA; Manns BJ; Ghali WA
    Arch Intern Med; 2006 Jan; 166(2):161-6. PubMed ID: 16432083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Consequences of intravascular contrast media on kidney function-- risk and prevention].
    Erley CM; Bader BD
    Rofo; 2000 Oct; 172(10):791-7. PubMed ID: 11111289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significant statistical heterogeneity in a meta-analysis of the usefulness of acetylcysteine for prevention of contrast nephropathy.
    Faddy SC
    Am J Cardiol; 2004 Aug; 94(3):414. PubMed ID: 15276125
    [No Abstract]   [Full Text] [Related]  

  • 17. [Contrast-induced acute renal failure].
    Giannattasio M
    G Ital Nefrol; 2005; 22(3):217-25. PubMed ID: 16001365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrast-induced nephropathy.
    McCullough PA; Soman SS
    Crit Care Clin; 2005 Apr; 21(2):261-80. PubMed ID: 15781162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandin E1: a new agent for the prevention of renal dysfunction in high risk patients caused by radiocontrast media? PGE1 Study Group.
    Koch JA; Plum J; Grabensee B; Mödder U
    Nephrol Dial Transplant; 2000 Jan; 15(1):43-9. PubMed ID: 10607766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrast-induced nephropathy.
    Kabalan SN; El-Imad BG; Geara AS
    J Med Liban; 2007; 55(1):29-38. PubMed ID: 17489305
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.